Achieve Life Sciences Announces Start of Phase 3 ORCA-2 Clinical Trial Evaluating Cytisinicline for Smoking CessationPRNewsWire • 10/07/20
Achieve Announces Presentation of Investigator-Led RAUORA Trial Data Demonstrating Significantly Fewer Side Effects with Higher Quit Rates for Cytisinicline (cytisine) Compared to Chantix® (varenicline) in First Head-to-Head Comparative StudyPRNewsWire • 09/18/20
Achieve Life Sciences Announces Results from Evaluation of Cytisinicline (cytisine) versus Chantix® (varenicline) in 5-HT3 Receptor Binding Assay StudyPRNewsWire • 09/18/20
Achieve Life Sciences Announces Presentation of Cytisinicline Data at the 20th Annual Society for Research on Nicotine & Tobacco Europe (SRNT-E) Virtual ConferencePRNewsWire • 09/10/20
Achieve Life Sciences, Inc. (ACHV) CEO Richard Stewart on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 08/09/20
Achieve Reports Financial Results for Second Quarter 2020 and Provides Update on Cytisinicline Development ProgramPRNewsWire • 08/06/20
Achieve Announces Patent Granted in the U.S. for Novel Analogs of Cytisinicline for Use in CNS and Addiction IndicationsPRNewsWire • 07/31/20
Achieve Life Sciences to Announce Second Quarter 2020 Financial Results and Host Conference Call and Webcast on August 6, 2020PRNewsWire • 07/28/20
Achieve Life Sciences Announces Pricing of $6 Million Registered Direct OfferingPRNewsWire • 06/29/20
Achieve Life Sciences, Inc. (ACHV) CEO Richard Stewart on Q1 2020 Results - Earnings Call TranscriptSeeking Alpha • 05/14/20
Achieve Reports Financial Results for First Quarter 2020 and Provides Update on Cytisinicline Development ProgramPRNewsWire • 05/14/20
Achieve Life Sciences, Inc.'s (ACHV) CEO Richard Stewart on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 03/13/20
Achieve Life Sciences, Inc. (ACHV) CEO Rick Stewart on Q3 2019 Results - Earnings Call TranscriptSeeking Alpha • 11/11/19
Achieve Life Sciences, Inc. (ACHV) CEO Rick Stewart on Q2 2019 Results - Earnings Call TranscriptSeeking Alpha • 08/09/19
Achieve Life Sciences Says Mid-Stage Data For Smoking Cessation Drug Accepted For Presentation At ConferenceBenzinga • 06/21/19
Achieve Life Sciences, Inc. (ACHV) CEO Rick Stewart on Q1 2019 Results - Earnings Call TranscriptSeeking Alpha • 05/16/19
Achieve Life Sciences, Inc. (ACHV) CEO Richard Stewart on Q4 2018 Results - Earnings Call TranscriptSeeking Alpha • 03/15/19